ArticleBMC biology2020

DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-κB and sensitize to alkylating chemotherapy.

Szymon J Szymura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.